Simulate the treatment plan before making the decision.
APEX matches your patient to thousands of historical twins across anatomy, hemodynamics, and comorbidities. Your care team sees comparative procedural trajectories, adverse event risks, and guideline eligibility before booking the table. A clinician always reviews and signs off.
Millions of high-stakes treatment decisions happen every year. Give your care team the confidence that they chose the optimal plan.
Today, care teams navigate complex treatment decisions using fragmented chart notes, siloed imaging studies, and manual guideline scouring.
Dr. Data built APEX to simulate the treatment plan before making the decision, matching your patient's exact profile to real historical cases at your institution and showing your care team what was chosen, and what happened next.
By providing high-dimensional outcome modeling and surveillance prior to the table, hospital schedules stay protected, margins are safeguarded, and every case makes the next treatment decision better. A licensed clinician always reviews and signs the chart.
Dr. Data participated in the 2026 Mayo Clinic Platform_Accelerate cohort, a 30-week program supporting digital health companies as they further develop their solutions using program resources and de-identified clinical data.
High-dimensional patient digital twins
Twins matched to identical phenotypes drawn from your own institution's historical case volume.
Mayo Clinic Platform_Accelerate startup
Selected cohort startup, validated against longitudinal de-identified records.
Care team retains 100% sign-off authority
Human-in-the-loop by construction: a licensed clinician reviews, edits, and digitally signs.
We run the simulation before the table.
Here is the path APEX walks for every case.
Ingest clinical and PACS records
Connects to EHR records, lab panels, and PACS DICOM cine studies. No manual entry, no chart-scouring.
Physician sets the match criteria
Age, sex, comorbidities, hemodynamics, and anatomical tolerances — the clinician defines the twin.
Simulate the matched twin
Optimal-transport matching across thousands of historical cases projects real comparative trajectories.
Care team reviews and signs
A cited, auditable consensus brief that the attending reviews and signs off with confidence.
APEX
Four specialized agents, coordinated by Dr. Data, match your patient to identical historical phenotypes across anatomy, hemodynamics, and comorbidities at your organization, showing what was chosen and what happened next.
Audits treatment options against ACC/AHA and ESC guidelines with line-level paragraph citations.
Segments fluoroscopy cines and CT runs for exact stenosis and annular clearance.
Matches your patient to historical twins and projects comparative outcomes and survival for each option.
Turns natural-language questions into population benchmarks that calibrate survival trends.
Four specialized agents. One decision-ready report.
The Digital Twin is the core of APEX. Four specialized agents — Clinical Guidelines, Imaging, Cohort Analytics, and the Heart Team synthesizer — exist to make that twin trustworthy, cited, and defensible. Dr. Data coordinates all of them.
76 M · severe calcific aortic stenosis (SAVR vs TAVR)
Matched against 3,842 historical twins across identical anatomy and STS-PROM 3.8%.
Patient took apixaban 5 mg BID this morning against the required 48-hour pre-procedural hold. Surfaced to the care team two days prior — protecting the scheduled room block and preventing acute access-site bleeding.
Cardiac CT reconstruction. Annular perimeter 76.4 mm (area 462 mm²), favorable for a 26 mm transcatheter prosthesis.
PERIMETER 76.4 MM · LM CLEARANCE 10.2 MMThe identical intermediate-risk cohort achieved lower 30-day procedural trauma with transfemoral TAVR over open SAVR sternotomy.
94.1% SURVIVAL PARITY · AVOIDED ICU 88.4%ACC/AHA 2020 VHD § 3.2 and ESC/EACTS 2021 recommend transfemoral TAVR (Class I, LoE A) for patients ≥ 75 with favorable vascular caliber.
CLASS I, LEVEL A · 6/6 AGREEMENTIsolated focal pLAD lesion (70–99%) with patent circumflex and right coronary artery.
SYNTAX 14 · SUITABLE FOR CONCOMITANT PCIHypertension, mild peripheral vascular disease, prior CVA without residual neurological deficit.
STS-PROM 3.8% · eGFR 58 ML/MINSynthesized recommendation: transfemoral TAVR via balloon-expandable valve. Ready for care team sign-off.
ONE-CLICK SIGN-OFF READYBuilt for the people who own the decision.
APEX is deployed where high-stakes treatment decisions get made: by the clinicians who make them, the systems that standardize them, and the organizations that measure them.
Care teams
Multidisciplinary teams, attending physicians, surgical specialists, and coordinators deliberating complex pathways daily. APEX speeds consensus without removing judgment from the loop.
Hospitals and networks
Department chairs, service-line directors, and networks standardizing treatment decisions across inpatient and outpatient sites — reducing variability and accelerating deliberation throughput.
Payers and research groups
Payers measuring decision appropriateness and outcomes researchers running retrospective or prospective cohort studies. APEX output is a data layer, not a black box.
Safe by design. Built for the way care teams work.
Built with practicing physicians. Outcome simulation and protocol adherence catch medication conflicts and clearance issues before surgery, not after.
The care team is always in the loop
Nothing reaches a patient or your EHR without a physician reviewing and signing it. Your EHR remains the source of truth, and there is zero autonomous ordering.
Single-tenant, zero model retraining
A signed BAA precedes any clinical data connection. Every deployment is an isolated, single-tenant US environment, encrypted in transit and at rest, never used to train public models.
Auditable to the source DICOM frame
Every stenosis measurement, annular perimeter, and guideline recommendation carries its source timestamp and frame coordinates back to the raw imaging series.
Validated on real historical cohorts
Trained and validated on longitudinal de-identified cohorts. Every simulation is grounded in real historical outcomes, not hypothetical black-box assumptions.
What Dr. Data APEX will never do
Anything outside the approved clinical protocol is surfaced and routed to your care team, never improvised around.
Meet your hospital's data posture, not the other way around.
Immediate cloud pilot access or an air-gapped on-premise installation wired into your PACS and EHR.
Hosted (SaaS)
Fastest pilotCloud-hosted in a HIPAA-configured environment with single sign-on and role-based access control.
On-premise
Zero PHI egressFor hospitals with data-residency or PHI-egress requirements. Runs on your own infrastructure.
System integration
Native workflowAPEX connects to PACS, imaging archives, and EHR sidebars via CDS Hooks or SMART-on-FHIR.
HIPAA, DICOM PS3.1–3.20, and HL7 FHIR R4 ready
No vendor lock-in. APEX outputs structured CDA documents, FHIR resources, and audit manifests.
Walk one of your own cases through APEX.
Thirty minutes with our clinical team: bring a de-identified case and watch the twin simulation, guideline audit, and heart-team deliberation run end to end.
111 NE 1st Street, 8th Floor #8966
Miami, FL 33132
Bring APEX to your heart team
Book a 30-minute walk-through. We will run a de-identified case end to end in the live product: guideline check, digital twin, imaging, cohort, and consensus report with our clinical team.
Walk-through requested
Thank you, {{ form.name }}. Our clinical team will reach out from info@drdatainc.com to {{ form.email }} within 24 hours with calendar coordinates and case overview materials.